inactivated serum (from healthy male donors) added in 10% concentration was used in all experiments. NI-IS were not preselected, but cloudy sera were excluded.
Cytotoxicity Assay. A modification of the method described by Vose et al. (28) has been used.
Target cells (106) were labeled in 0.5 ml medium by the addition of 100/~Ci ~ICr (as sodium chromate; 100-350 ~Ci//~g sp act; The Radiochemical Centre, Amersham, Buckinghamshire, England). After incubation for 2 h at 37°C the cells were washed twice. They were further incubated for 1 h, washed twice, and resuspended in culture medium. Target cells (5 × 10:~/ well) were dispensed into wells of round-bottom microplates (96 wells/plate; Titertek, Flow Laboratories, Ltd.). Lymphocytes were then added to give an effector:target ratio of 50:1. The final vol in each well was 0.2 ml. The plates were centrifuged for 10 s at 800 g. After a 4-h incubation at 37°C, the supernates and the pellets were collected separately (by means of Titertek) and the radioactivity in the supernate and pellet was measured in a gamma counter. Spontaneous ~Cr release was measured from target cells incubated in medium; maximum ~lCr release was obtained by lysis of the cells with detergent (Triton X-100, Sigma Chemical Co., St. Louis, Mo.).
Test evaluation. The percentage of ~lCr release was calculated from the following formula:
(counts in supernate/counts in supernate and pellet) × 100. The percent specific 51Cr release was then determined by the following formula: (percent release in test -percent spontaneous release)/(percent maximum release -percent spontaneous release) × 100. Tests in which the spontaneous release exceeded 50% were disregarded. Statistical significances were calculated on the triplicates by the Student's t test. A further criteria for the positivity of ALC was that the level of specific 51Cr release had to be twice over the control. This was obtained by the experiments performed between lymphocytes from 47 healthy donors and tumor biopsy cells from 45 patients. On the basis of these results 20% specific release was chosen as limit for positivity. Specific 5XCr release >20% was always significant by the Mann-Whitney U test and was arbitrarily chosen as limit for positivity. This may be too high, and, therefore, it is likely that some of the positive effects are not considered. In the present series, the cytotoxic efficiencies of untreated and IF-treated lymphocytes were compared; thus, the limit for determining the positivity is of secondary importance. Positivity for changes of cytotoxicity caused by IF was established on the basis of statistical significance between counts per minute values of the triplicates. Table II presents the results of an experiment in which two patients (malignant mesenchymal tumor 1115 and liposarcoma 011 1) and one healthy donor were involved. After pretreatment of the lymphocytes with IF, the NK activities were measured as the elevated anti-K-562 effect. Except for the effect of the 0111 lymphocytes on the 1115 targets, the effects against primary biopsy cells were weaker than against K-562. IF treatment regularly enhanced the killing of allogeneic targets. This was not the case for ALC.
Results

Effect of IF on Lymphocyte Cytotoxicity Against Primary Tumor Biopsy Cells.
The results of an experiment with lymphocytes from two hypernephroma patients and one healthy blood donor are given in Table III . The NK activity of the patients, as measured against Molt-4, was weaker than that of the control donor. The strong NK activity of the lymphocytes of the healthy donor is also reflected by the cytotoxicity against the biopsies. The lymphocytes of patient 0509 killed the autologous tumor cells. This activity was not elevated by IF pretreatment, whereas allo-killing was induced. The lymphocytes of patient 0508 were inactive against both the autologous and the allogeneic tumor cells. IF treatment of the lymphocytes induced strong cytotoxicity against the allogeneic biopsy cells. Table IV shows a test with lymphocytes and tumor cells from a synovial sarcoma (1117) and an osteosarcoma (1020) patient. The standard NK activity (anti-K-562) of the lymphocytes of the patients was autgmented by IF. Cytotoxicity against the biopsy cells was increased by IF only in the allogeneic combinations.
The summary of ALC experiments with lymphocytes from 25 tumor patients is presented in Fig. 1 a and Table V . ALC occurred in 7 (28%) cases. In an additional four cases, the specific SlCr release was between 10 and 20%. In 24 of 25 cases, incubation of the lymphocytes with IF did not significantly change the level of ALC, whereas in one it decreased the killing potential (of the 24 cases in which the change was not significant, the 51Cr-release values were higher in 10 and lower in 10 cases).
The results of cytotoxicity against allogeneic biopsy targets with lymphocytes from 46 healthy donors and 24 tumor patients are presented in Fig. 1 b and c, respectively. The controls were active in 7 of 50 (14%) tests ( Fig. 1 b) , and, in 5 of these 7, IF increased the cytotoxic efficiency. Of the 43 negative tests, IF treatment caused significant cytotoxicity in 22. The specific 51Cr release was somewhat enhanced in an additional 10 cases, diminished in 7, and equal to that of untreated samples in 6. The :"% .
• o oo fo ~ ~o 4b ~b increase (_ SE) in the mean percent specific 51Cr release with IF-treated lymphocytes from healthy donors was 12 ± 2.6, and this was statistically significant (P < 0.001).
The results with the tumor patients were similar. They showed a significantly lower proportion of allogeneic cytotoxicity, i.e., in 2 of 37 (5%) of the tests (Fig. 1 c) . In 18 of 37 tests, IF-treated lymphocytes exhibited significant cytotoxicity. The specific 51Cr release was elevated in an additional eight cases, diminished in eight, and equal to lower NK efficiency of the lymphocytes of the tumor patients is reflected by the lower frequency of allo-killing (5%) compared with the 14% obtained with effectors from healthy donors. There was no significant difference between the proportion of IAKpositive tests of the patients and controls with allogeneic biopsy targets (49 and 52%, respectively).
Eight osteosarcoma patients received IF therapy at the time of tumor and blood sampling. The results with this group of patients did not differ from the general pattern either in the efficiency of the effectors or the sensitivity of the targets.
Lymphocytes from 12 patients were assayed against the K-562 and/or Molt-4 lines. In all 26 tests (Fig. 2 ) the IAK was elevated over the NK. Repeated tests gave similar results. In accordance with previous findings, the NK efficiency of lymphocytes from healthy donors was stronger than that of the tumor patients. The mean 51Cr-release values in healthy donors and tumor patients was 44.8 and 14.5% for K-562, and for Molt-4 63.4 and 27.6%, respectively.
Alteration of the Cytotoxic Susceptibility of Biopsy Cells after Cultivation.
In three experiments, the tumor cells were used as targets directly, after 5-6 d of cultivation, or after preservation in frozen state. The effector cells were used with and without pretreatment with IF (Table VI) . In accordance with the above described results, IF did not affect the reactivity against fresh or frozen stored autologous cells. Lymphocytes of three healthy individuals and of one tumor patient (1 131) showed no NK against fresh or frozen stored allogeneic targets, whereas IAK was efficient in two of four tests. After 6 d in culture, the cytotoxic sensitivity of the biopsy cells increased, and, in two of three tests, the ALC was positive (2259 and 0788). All three tests were positive after IF treatment of the lymphocytes.
In two of four cases, the cultured targets were NK sensitive, and in all four tests IAK sensitive.
Discussion
The lack of induction of ALC by in vitro IF treatment of the lymphocytes does not exclude the fact that in the complexity of the prevailing events, in vivo administration of IF can enhance the antitumor activity of the immune system. The immune response comprises interactions between several components, humoral and cellular, and the outcome might be influenced by IF acting on other levels than the direct cytotoxic effect of lymphocytes.
In previous experiments, ALC, i.e., cytotoxicity of the patients lymphocytes against their own tumor cells, was obtained in 27% of 198 cases. The effects were usually weak. The reactivity was exerted by the T cell-enriched subset and mainly autologous tumor cells were affected (29, 18) . Although not proven, we may consider the in vitro cytotoxicity as a manifestation of antitumor autoimmunity. Induction of DNA synthesis in lymphocytes by the autologous tumor biopsy cells (autologous tumor stimulation [ATS] ) is an additional parameter that suggests the occurrance of a tumor-specific cellular reaction (30, 31) . ATS was demonstrated in higher proportion of cases (68%) than ALC (32) . The reason why ALC was not influenced by IF treatment of the lymphocytes is unclear. It may be a result of the low number of antigen-recognizing lymphocytes and/or the weak expression of the relevant antigens on the targets.
In studies concerned with the characteristics of the NK, freshly harvested targets were usually resistent or were weakly sensitive in short-term cytotoxicity tests (16) . In accordance, human tumor biopsy cells were rarely killed by allogeneic lymphocytes (18, 19) . As shown in our results, when killing occurred, the effectors were exceptionally active against the standard NK targets.
In one study, designed to clarify the conditions that influence the NK susceptibility of the target, it was shown that the sensitivity of the same mouse tumor line changed depending upon whether it was derived from cultures or from animals (17) . Our results with the human biopsy cells show a similar phenomenon. The reactivities that appear after in vitro cultivation may be the consequence to a quantitative or qualitative change in the expression of surface antigens. Such changes after explantation have in fact been demonstrated in a murine lymphoma system both for the histocompatibility (decrease) and virus-determined antigens (increase) (33) . The TL antigen expressed on certain murine leukemias was also found to be modulated, it was detectable on cells kept in vitro although absent from cells harvested from immunized animals (34) . Another alternative may be that in the conditions prevailing in culture those cell membrane properties that determine the sensitivity for cytotoxicity are changed. An increase in the sensitivity toward complement-mediated immune killing was observed after treatment of the targets with antimetabolites, perhaps because of an effect on cell membrane repair mechanisms (35) .
We may also consider the possibility that IF is responsible for the relatively low sensitivity of primary cells (10) . Immune IF may be produced in the patients in the course of an anti-tumor response, and this may cause the relatively low NK sensitivity of the tumor cells. These alternatives are speculative, and it remains to be seen what the factor is that is responsible for the changed susceptibility toward lymphocytemediated killing after explantation.
The experiments revealed an interesting aspect concerning the involvement of the histocompatibility antigens in the natural killing. In the majority of NK studies, cultured lines and most often tumor lines were used as targets. The recognition seems not to be specific because sensitive cells are killed without discrimination. Tests performed with lymphocytes, of various individuals often differ in efficiency, but the ranking order of damage exerted on the various targets is similar (36, 37) .
NK phenomenon is operationally defined as the cytotoxicity exerted by lymphocytes harvested from individuals without known sensitization history toward the target. IF treatment is known to enhance this effect, and the effector cells of NK and IAK were shown to be in the same subsets (20) .z IAK performed with the lymphocytes of donors without known immunization toward the target may be regarded as an enhanced NK phenomenon and also affects such targets that have low NK sensitivity. We may consider the situation as follows: The individual lymphocytes in the population function at various levels of intensity. For the different targets, the threshold of the intensity necessary to bring about damage seems to differ, hence the differences in the proportion of target killed by a given number of effector cells. It is unknown whether the critical factor acts at the event of establishment of the contact or at the event of the lethal hit. The results of cold target inhibition experiments would suggest the former because the competitive capacity of a particular target usually parallels its cytotoxic sensitivity. Two sets of experiments provided evidence that the elevated IAK, as compared with NK, in a given system is a result of recruitment of new cells that can kill the target, rather than action on the already active cells in such a way that each kill an increased number of targets. These experiments were (a) comparative limiting dilutions of effectors in NK and IAK using the same target, which showed an increased number of active samples in IAK; 2 and (b) elimination of NK cells by preexposure of the lymphocytes to fibroblast monolayer that left potentially active cells inducible by IF treatment (38) . In addition, results with an in vivo system also pointed to this mechanism. When rats were depleted of NK activity by radiation or drug treatment and injected with IF inducers, NK cells were found to reappear within a short time (39) .
A likely explanation for the allogeneic killing induced by IF in our experiments is a polyclonal activation of the cytotoxic potential that is then manifested by the lymphocytes committed to the alloantigen specificities expressed on the particular target cells. The role of the specific receptors may be the establishment of contact between the interacting cells. Experiments concerned with the nature of NK and IAK have not yet revealed the recognition of alloantigens, although it may be the cause of a certain degree of specificity and is often detectable superimposed on cross-reactivities. Some indications for the recognition of alloantigens were seen when in vivo activated murine killer cells were tested on macrophage targets in a 16-h assay. The effect was weaker on syngeneic compared with allogeneic targets (40) . However, in other series of experiments efficient killing of syngeneic primary target of nontumor origin such as thymus cells was reported (41) . These latter effects may, however, also represent a killing as a result of the recognition of cell surface antigens. Mice are known to harbor endogenous viruses that impose surface antigens on certain cell types, and these are known to be recognized by the immune system (42) . It seems that the conditions to reveal the alloantigen-determined killing have to be strict in the sense that cultured target cells have to be avoided.
The activation of cytotoxic precursors by IF and the manifestation of cytotoxicity toward cells that carry alien histocompatibility antigens is similar to the findings with mitogen-activated murine cells. The murine system has the advantage that the influence of the major histocompatibility antigens can be easily studied in detail with co-isogeneic strains. The phenomenon described by several authors (43-45) is as follows: Spleen cells were activated in vitro with Concanavalin A (Con A), and this killing effect was tested after the lectin was removed by incubation with a-methyl-Dmannoside. Cytotoxicity was exerted by the activated lymphocytes only toward targets that expressed alien major histocompatibility complex (MHC) locus-determined antigens. Differences in the loci of minor histocompatibility antigens and expression of tumor-related antigens were not sufficient to bring about this reaction. This type of cytotoxicity differed from that obtained in the presence of lectin, which was indiscriminative and also affected histocompatibile cells. The interpretation proposed was that Con A activates precursors for expression of cytotoxic potential and in a particular test the clone that was committed to the MHC antigens present on the target exerted the killing. Because it is known that the frequency oflymphocytes that recognize MHC antigens is high, such cytotoxicities are often measurable without the necessity of the enlargement of the reactive clone. This mechanism may also be applicable to the NK and IAK systems due to the restriction to allogeneic targets.
The search for a particular antigen responsible for the NK effect did not give support for the existence of a well-defined entity. It is possible that membrane properties of cultured cell lines contribute to the interaction with the killer cells. Similar to the cytotoxicity in the presence of lectins, such interactions have a certain specificity inasmuch as targets from the same species are affected with considerably higher efficiency than xenogeneic targets that are sensitive to the NK exerted by the lymphocytes of their own species (36, 46) . It is known that the number of lymphocytes that recognize cell surface antigens of an alien species is relatively low. A speciesspecific recognition on the cell membrane level has also been indicated when T cells and thymocytes were admixed to various target cells. They attached to cells in a species-specific pattern, distinguishing their own and closely related species (47) .
The cell membrane property acquired in culture conditions that contribute to the suicidal interaction with the lymphocytes is unknown. With freshly harvested cells this factor is absent, and the effect exhibited by lymphocytes of the unprimed donors (NK) may be the consequence of a certain, individually variable, degree of T cell activation (the active cells have been shown to be within the T subset) (48, 49) . Those activated T cells that recognize the antigens determined by MHC on the target can establish the contact and exert the killing function. IF or IF inducers recruit potential killer cells. All evidences point to the fact that the lymphocyte cytotoxicities without manipulation and after IF activation are similar in the ranking order of the efficiencies exhibited by various subsets and in the sensitivities of various targets. According to this view, the NK (and IAK) effect would be related to cytotoxic T lymphocytes when assayed on fresh targets, whereas with some cultured cell lines tested in short-term assays, as a result of yet undefined properties of their plasma membrane, events similar to the cytotoxicity in the presence of lectins could occur.
Summary
Blood lymphocytes of patients with solid tumors were assayed for cytotoxicity against autologous and allogeneic primary tumor cells. The lymphocytes killed autologous tumor cells in 7 of 25 cases (28%) and allogeneic tumor cells in 2 of 37 tests (5%). Lymphocytes from healthy donors were rarely cytotoxic for the biopsy cells, which indicates that these cells have low natural killer sensitivity.
The autoreactivity that may reflect the immunological recognition of tumor cells was not altered by pretreatment of the effectors with interferon (IF). In contrast, killing of allogeneic tumor biopsy cells was induced by IF in ~50% of tests, with the lymphocytes of both the tumor patients and the healthy donors. The mechanism of the alloreactivity is most likely a consequence of IF-induced polyclonal activation of cytotoxic potential and the lymphocytes that are committed to recognize the alloantigens expressed on the particular target manifest the killing function.
When the biopsy cells were explanted and kept in culture for 5-6 d, their susceptibility for the lymphocyte damage increased, and they were killed by the IFtreated ceils also in autologous combinations. Whether this change in sensitivity is a result of qualitative or quantitative changes in antigen expression or of other changes in the properties of the cell membrane is unknown.
